| Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy (NCT06382103) | Shanghai Zhongshan Hospital | 2024-05-15 |
| Comparing the TDTP-RECIST With RECIST 1.1 and Other Volumetric Evaluation Methods for Assessing the Therapeutic Efficacy of Irregular Malignant Tumors (NCT07319767) | Shanghai Zhongshan Hospital | 2024-05-14 |
| A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer (NCT06356623) | Shanghai Zhongshan Hospital | 2024-05-05 |
| Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT (NCT06319131) | Shanghai Zhongshan Hospital | 2024-05-01 |
| Resistance Swallowing Training in Patients With Tracheotomy (NCT06372795) | Shanghai Zhongshan Hospital | 2024-05-01 |
| PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7 (NCT06423144) | Shanghai Zhongshan Hospital | 2024-05-01 |
| LINC01844 as a Diagnostic Biomarker for POCD in Elderly Patients (NCT06387836) | Shanghai Zhongshan Hospital | 2024-04-23 |
| Artificial Intelligence-assisted Insulin System in Type 2 Diabetes in General Wards (NCT06319300) | Shanghai Zhongshan Hospital | 2024-04-19 |
| Non-Invasive Lung Water Monitoring in Pulmonary Hypertension (NCT06942871) | Shanghai Zhongshan Hospital | 2024-04-01 |
| Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application (NCT06335576) | Shanghai Zhongshan Hospital | 2024-03-31 |
| IVUS CHIP China Registry (NCT06274645) | Shanghai Zhongshan Hospital | 2024-03-12 |
| Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer (NCT06225622) | Shanghai Zhongshan Hospital | 2024-03-11 |
| Prevalence and Affecting Factors of Sleep and Circadian Rhythm Disorders in ICU (NCT06346613) | Shanghai Zhongshan Hospital | 2024-03-07 |
| Delirium Phenotypes and Subsequent Impairment During Transition From ICU to Hospital Wards (NCT07193797) | Shanghai Zhongshan Hospital | 2024-03-01 |
| Surgeons' Mental Distress and Risks After Severe Complications Following Emergency Surgery (NCT05864443) | Shanghai Zhongshan Hospital | 2024-03-01 |
| Preoperative Nutritional Status Associated With Delayed Discharge in Elderly Patients Undergoing Gastrectomy (NCT06261151) | Shanghai Zhongshan Hospital | 2024-03-01 |
| Artificial Intelligence-enhanced Electrocardiogram Diagnoses and Predicts Future Regurgitant Valvular Heart Diseases (NCT06475157) | Shanghai Zhongshan Hospital | 2024-03-01 |
| Home-based Mobile Guided Exercise-based Cardiac Rehabilitation Among Patients Undergoing TAVR (NCT05989594) | Shanghai Zhongshan Hospital | 2024-03-01 |
| Carotid Atherosclerosis in Predicting Coronary Artery Disease (NCT06253962) | Shanghai Zhongshan Hospital | 2024-02-10 |
| Perioperative Efgartigimod for Thymoma and Myasthenia Gravis (NCT06221501) | Shanghai Zhongshan Hospital | 2024-02-01 |
| The SLEEP-CARE Study (NCT06336408) | Shanghai Zhongshan Hospital | 2024-02-01 |
| Efficacy of Vitamin B1 in Familial Adenomatous Polyposis Patients. (NCT06649825) | Shanghai Zhongshan Hospital | 2024-01-08 |
| HRS9531 Controls Weight Regain in Obese Subjects (NCT06287437) | Shanghai Zhongshan Hospital | 2024-01-01 |
| A Study of Sunvozertinib Combined With Anlotinib in Local Advanced or Metastatic Non-small Cell Lung Cancer (NCT06182761) | Shanghai Zhongshan Hospital | 2024-01-01 |
| Diagnosis of HCM With AI-ECG (NCT06287892) | Shanghai Zhongshan Hospital | 2024-01-01 |
| Second-line Zimberelimab and SIRIOX Chemotherapy for Patient With Previously AG Chemotherapy Treated Pancreatic Cancer (NCT06166589) | Shanghai Zhongshan Hospital | 2024-01-01 |
| Comprehensive Assessment on Diagnostic and Prognostic Performance of Coronary Physiological Indices (NCT06127420) | Shanghai Zhongshan Hospital | 2023-12-06 |
| Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma (NCT07266493) | Shanghai Zhongshan Hospital | 2023-12-01 |
| Individualized PEEP Titration on Postoperative Pulmonary Complications (NCT06150079) | Shanghai Zhongshan Hospital | 2023-11-30 |
| Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury. (NCT06164639) | Shanghai Zhongshan Hospital | 2023-11-28 |
| Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure (NCT06102031) | Shanghai Zhongshan Hospital | 2023-11-01 |
| Surufatinib Combined With KN046 and AG Regimen Chemotherapy as First-Line Treatment for Unresectable Advanced Pancreatic Cancer (NCT05832892) | Shanghai Zhongshan Hospital | 2023-11-01 |
| The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI (NCT06304779) | Shanghai Zhongshan Hospital | 2023-10-31 |
| Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors (NCT06031480) | Shanghai Zhongshan Hospital | 2023-10-31 |
| High-risk Features of Coronary Lesions in CTA and OCT (NCT06089343) | Shanghai Zhongshan Hospital | 2023-10-01 |
| FreeFlow Percutaneous Atrial Septal Shunt for IPAH (NCT06605794) | Shanghai Zhongshan Hospital | 2023-09-11 |
| Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC (NCT05987826) | Shanghai Zhongshan Hospital | 2023-08-01 |
| Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody (NCT05994001) | Shanghai Zhongshan Hospital | 2023-08-01 |
| Impact of Preoperative Serum Albumin Level on Postoperative Outcomes in Chinese HCC Patients Treated With Surgery (NCT05970159) | Shanghai Zhongshan Hospital | 2023-08-01 |
| Quality of Life in Patients Treated With Leadless Pacemakers (NCT05958836) | Shanghai Zhongshan Hospital | 2023-07-01 |
| The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study (NCT05965115) | Shanghai Zhongshan Hospital | 2023-07-01 |
| Portal Vein Occlusion is a Valuable Predictor for Postoperative Nausea and Vomiting (NCT05894408) | Shanghai Zhongshan Hospital | 2023-06-15 |
| Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome (NCT05740319) | Shanghai Zhongshan Hospital | 2023-06-10 |
| The Pathogenesis and Prognostic Factors of Lymphoma (NCT06203652) | Shanghai Zhongshan Hospital | 2023-06-05 |
| PDO/PDO-TIL/PDOTS for Drug Screen (NCT05913141) | Shanghai Zhongshan Hospital | 2023-06-01 |
| Surgeons' Mental Distress and Risks After Severe Complications Following Radical Gastrectomy (NCT05782205) | Shanghai Zhongshan Hospital | 2023-06-01 |
| Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer (NCT05848154) | Shanghai Zhongshan Hospital | 2023-06-01 |
| Consistency of Carotid Doppler Blood Flow and Thermodilution Technique (NCT05944146) | Shanghai Zhongshan Hospital | 2023-05-31 |
| IL-8+ naïve T Cells as a Biomarker for Thymoma Identification (NCT05255965) | Shanghai Zhongshan Hospital | 2023-05-02 |
| Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain (NCT05857904) | Shanghai Zhongshan Hospital | 2023-05-01 |
| Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients (NCT07321613) | Shanghai Zhongshan Hospital | 2023-05-01 |
| Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation (NCT05761717) | Shanghai Zhongshan Hospital | 2023-04-20 |
| A Single-center Observational Clinical Trial of Stereotactic Radiotherapy on Metastatic Spinal Tumors Using TomoTherapy (NCT05808998) | Shanghai Zhongshan Hospital | 2023-04-01 |
| Multimodal Al for Precision Diagnosis of Esophageal Cancer (NCT07629921) | Shanghai Zhongshan Hospital | 2023-03-01 |
| Longitudinal Data Registry of Plasma Cell Dyscrasia (NCT06760052) | Shanghai Zhongshan Hospital | 2023-03-01 |
| Efficacy of CeraVe® Moisturizing Cream on Skin Pruritus in Elderly Patients (NCT05779150) | Shanghai Zhongshan Hospital | 2023-02-26 |
| A Prospective Study on Clinical Effectiveness After SMILE Versus SMILE Xtra in Myopia (NCT06973278) | Shanghai Zhongshan Hospital | 2023-02-01 |
| A Randomized Controlled Trial Comparing Clinical Effectiveness of SMILE Versus SMILE Xtra in Myopia (NCT06992011) | Shanghai Zhongshan Hospital | 2023-02-01 |
| Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma (NCT05701553) | Shanghai Zhongshan Hospital | 2023-01-26 |
| Changes in Lung Aeration and Inspiratory Effort With and Without Awake Prone (NCT05719103) | Shanghai Zhongshan Hospital | 2023-01-09 |
| Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma Surgery (NCT06448195) | Shanghai Zhongshan Hospital | 2023-01-01 |
| Determine the Effects of Prone Positioning and NO in COVID-19 ARDS by EIT (NCT05715762) | Shanghai Zhongshan Hospital | 2022-12-21 |
| Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS. (NCT05715788) | Shanghai Zhongshan Hospital | 2022-12-21 |
| The Diagnostic and Prognostic Value of Speckle Tracking Imaging in Septic Cardiomyopathy (NCT05624619) | Shanghai Zhongshan Hospital | 2022-12-18 |
| Explainable Insulin Decision-making System to Assist Physicians in Diabetes Management (NCT06434584) | Shanghai Zhongshan Hospital | 2022-12-10 |
| Quick Recognition of Aortic Dissection (NCT05699395) | Shanghai Zhongshan Hospital | 2022-12-01 |
| Effects and Safety of Diabetic GUideline Algorithm Implementation Performed by Primary Care Physicians in the Community (NCT05349955) | Shanghai Zhongshan Hospital | 2022-11-21 |
| Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO (NCT04135677) | Shanghai Zhongshan Hospital | 2022-11-11 |
| Ultrasound Evaluations of Diaphragm and Intercostal Muscle to Predict the Failure of High-Flow Nasal Cannula Therapy (NCT06375538) | Shanghai Zhongshan Hospital | 2022-10-21 |
| Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (NCT05446935) | Shanghai Zhongshan Hospital | 2022-10-01 |
| Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma (NCT05389527) | Shanghai Zhongshan Hospital | 2022-09-30 |
| Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer (NCT05561699) | Shanghai Zhongshan Hospital | 2022-09-28 |
| Impact of Health Lifestyle on Body Weight (NCT05608226) | Shanghai Zhongshan Hospital | 2022-09-15 |
| Weight Cycle Post Intervention (NCT05556577) | Shanghai Zhongshan Hospital | 2022-09-15 |
| Dezoxide Suppresses Sufentanil-induced Cough (NCT05532449) | Shanghai Zhongshan Hospital | 2022-09-12 |
| Blood Purification Therapy With Dual-cannula in Jugular-femoral Venous (NCT05510713) | Shanghai Zhongshan Hospital | 2022-09-01 |
| Organ Preservation Strategy of Total Neoadjuvant Chemoradiotherapy for Low Rectal Carcinoma (NCT05563922) | Shanghai Zhongshan Hospital | 2022-09-01 |
| A Prospective Observation Registry Study on the Alimentary Reconstruction After Radical Proximal Gastrectomy (NCT05539105) | Shanghai Zhongshan Hospital | 2022-08-22 |
| Hydrogen-Oxygen Generator With Nebulizer for Rehabilitation Treatment of COVID-19 (NCT05504460) | Shanghai Zhongshan Hospital | 2022-08-12 |
| Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction (NCT05531955) | Shanghai Zhongshan Hospital | 2022-08-05 |
| Efficacy and Safety of Radiotherapy in Oligoprogressive HCC Following First-line PD-1 Therapy (NCT06870942) | Shanghai Zhongshan Hospital | 2022-07-28 |
| Consistency of Electrical Cardiometry and Pulmonary Artery Catheter (NCT05587400) | Shanghai Zhongshan Hospital | 2022-07-27 |
| Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer (NCT05437692) | Shanghai Zhongshan Hospital | 2022-07-15 |
| Tislelizumab Plus Cetuximab and Irinotecan vs Third-line Standard-of-care in Refractory mCRC (NCT05278351) | Shanghai Zhongshan Hospital | 2022-07-13 |
| Safety and Feasibility of TRISKELE in Severe AS (NCT05391191) | Shanghai Zhongshan Hospital | 2022-07-06 |
| A Multi-center Study of Apixaban(APPROACH) (NCT04550637) | Shanghai Zhongshan Hospital | 2022-07-04 |
| Effect of RIPC on the Prevention of POD in Patients Undergoing Cardiac Surgery (NCT05434455) | Shanghai Zhongshan Hospital | 2022-07-01 |
| The Effect of Dihydroartemisinin in PCOS (NCT05465135) | Shanghai Zhongshan Hospital | 2022-07-01 |
| Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer (NCT05333809) | Shanghai Zhongshan Hospital | 2022-07-01 |
| M-TACE Treatment for Unresectable Hepatocellular Carcinoma (NCT05875558) | Shanghai Zhongshan Hospital | 2022-07-01 |
| Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy (NCT05420480) | Shanghai Zhongshan Hospital | 2022-07-01 |
| The Multicenter Clinical Trial of a Novel TEER Decive (V-CLASP Trial) (NCT05391802) | Shanghai Zhongshan Hospital | 2022-06-30 |
| Insulin Titration System Based on Deep Learning (NCT05409391) | Shanghai Zhongshan Hospital | 2022-06-15 |
| Impact of Partial Capsule Decortication on Device-related Infection in Patients Receiving Cardiac Implantable Electronic Device Replacement (NCT05390216) | Shanghai Zhongshan Hospital | 2022-06-05 |
| Efficacy and Safety of BV With Tislelizumab for the Treatment of CD30+ Relapsed/Refractory NK/T-cell Lymphoma (NCT05316246) | Shanghai Zhongshan Hospital | 2022-06-01 |
| A Pilot Study of Neoadjuvant TACiE in Locally Advanced Gastric Cancer (NCT05396326) | Shanghai Zhongshan Hospital | 2022-06-01 |
| Neoadjuvant TACiE in Locally Advanced Gastric Cancer (NCT05346874) | Shanghai Zhongshan Hospital | 2022-06-01 |
| Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC (NCT05213312) | Shanghai Zhongshan Hospital | 2022-06-01 |
| CSP vs EMR for >6mm Superficial Non-ampullary Duodenal Tumors (NCT05428553) | Shanghai Zhongshan Hospital | 2022-06-01 |
| A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19. (NCT05386420) | Shanghai Zhongshan Hospital | 2022-05-23 |